Annual Operating Profit
-$4.75 M
-$2.16 M-83.26%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual operaing income is currently -$4.75 million, with the most recent change of -$2.16 million (-83.26%) on 01 December 2023. During the last 3 years, it has fallen by -$4.69 million (-8240.95%). LIPO annual operating profit is now -8240.95% below its all-time high of -$56.90 thousand, reached on 01 December 2020.LIPO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.38 M
-$426.80 K-44.82%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly operating income is currently -$1.38 million, with the most recent change of -$426.80 thousand (-44.82%) on 01 September 2024. Over the past year, it has dropped by -$320.60 thousand (-30.29%). LIPO quarterly operating profit is now -305.71% below its all-time high of -$339.90 thousand, reached on 01 June 2021.LIPO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$4.61 M
-$126.30 K-2.82%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM operating income is currently -$4.61 million, with the most recent change of -$126.30 thousand (-2.82%) on 01 September 2024. Over the past year, it has increased by +$363.50 thousand (+7.31%). LIPO TTM operating profit is now -651.71% below its all-time high of -$612.90 thousand, reached on 01 March 2021.LIPO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -30.3% | +7.3% |
| 3 y3 years | -8241.0% | -213.3% | -140.5% |
| 5 y5 years | - | - | - |
LIPO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8241.0% | at low | -283.8% | +12.5% | -140.5% | +9.7% |
| 5 y | 5 years | -8241.0% | at low | -305.7% | +12.5% | -651.7% | +9.7% |
| alltime | all time | -8241.0% | at low | -305.7% | +12.5% | -651.7% | +9.7% |
Lipella Pharmaceuticals Common Stock Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.38 M(+44.8%) | -$4.61 M(+2.8%) |
| June 2024 | - | -$952.20 K(-21.8%) | -$4.48 M(-12.2%) |
| Mar 2024 | - | -$1.22 M(+15.0%) | -$5.10 M(+2.7%) |
| Dec 2023 | -$4.75 M(+83.3%) | -$1.06 M(-15.5%) | -$4.97 M(+16.4%) |
| Sept 2023 | - | -$1.25 M(-20.5%) | -$4.27 M(+14.5%) |
| June 2023 | - | -$1.58 M(+45.3%) | -$3.73 M(+27.0%) |
| Mar 2023 | - | -$1.08 M(+201.8%) | -$2.94 M(+13.4%) |
| Dec 2022 | -$2.59 M | -$359.30 K(-49.6%) | -$2.59 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$712.60 K(-8.8%) | -$2.67 M(+7.6%) |
| June 2022 | - | -$781.10 K(+6.0%) | -$2.48 M(+21.6%) |
| Mar 2022 | - | -$736.70 K(+67.4%) | -$2.04 M(+6.5%) |
| Dec 2021 | -$1.92 M(+3267.0%) | - | - |
| Dec 2021 | - | -$440.20 K(-15.8%) | -$1.92 M(+29.8%) |
| Sept 2021 | - | -$522.90 K(+53.8%) | -$1.48 M(+54.9%) |
| June 2021 | - | -$339.90 K(-44.5%) | -$952.80 K(+55.5%) |
| Mar 2021 | - | -$612.90 K | -$612.90 K |
| Dec 2020 | -$56.90 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual operaing income?
- What is the all time high annual operating profit for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly operating income?
- What is the all time high quarterly operating profit for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly operating profit year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM operating income?
- What is the all time high TTM operating profit for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM operating profit year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual operaing income?
The current annual operating profit of LIPO is -$4.75 M
What is the all time high annual operating profit for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual operaing income is -$56.90 K
What is Lipella Pharmaceuticals Common Stock quarterly operating income?
The current quarterly operating profit of LIPO is -$1.38 M
What is the all time high quarterly operating profit for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly operating income is -$339.90 K
What is Lipella Pharmaceuticals Common Stock quarterly operating profit year-on-year change?
Over the past year, LIPO quarterly operating income has changed by -$320.60 K (-30.29%)
What is Lipella Pharmaceuticals Common Stock TTM operating income?
The current TTM operating profit of LIPO is -$4.61 M
What is the all time high TTM operating profit for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM operating income is -$612.90 K
What is Lipella Pharmaceuticals Common Stock TTM operating profit year-on-year change?
Over the past year, LIPO TTM operating income has changed by +$363.50 K (+7.31%)